These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25945047)
1. Poly(d,l-lactide-co-glycolide)-chitosan composite particles for the treatment of lung cancer. Arya N; Katti DS Int J Nanomedicine; 2015; 10():2997-3011. PubMed ID: 25945047 [TBL] [Abstract][Full Text] [Related]
2. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor. Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053 [TBL] [Abstract][Full Text] [Related]
3. PLGA-based microparticles loaded with bacterial-synthesized prodigiosin for anticancer drug release: Effects of particle size on drug release kinetics and cell viability. Obayemi JD; Danyuo Y; Dozie-Nwachukwu S; Odusanya OS; Anuku N; Malatesta K; Yu W; Uhrich KE; Soboyejo WO Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():51-65. PubMed ID: 27207038 [TBL] [Abstract][Full Text] [Related]
4. The intracellular uptake ability of chitosan-coated Poly (D,L-lactide-co-glycolide) nanoparticles. Kim BS; Kim CS; Lee KM Arch Pharm Res; 2008 Aug; 31(8):1050-4. PubMed ID: 18787796 [TBL] [Abstract][Full Text] [Related]
5. A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment. Yuan X; Ji W; Chen S; Bao Y; Tan S; Lu S; Wu K; Chu Q Int J Nanomedicine; 2016; 11():2119-31. PubMed ID: 27307727 [TBL] [Abstract][Full Text] [Related]
6. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P; Xu Y; Zeng C; Ren H; Peng M Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597 [TBL] [Abstract][Full Text] [Related]
7. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response. Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314 [TBL] [Abstract][Full Text] [Related]
8. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related]
9. Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations. Zhang Z; Wang X; Li B; Hou Y; Yang J; Yi L Drug Deliv; 2018 Nov; 25(1):166-177. PubMed ID: 29299936 [TBL] [Abstract][Full Text] [Related]
10. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor. Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614 [TBL] [Abstract][Full Text] [Related]
11. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method. Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303 [TBL] [Abstract][Full Text] [Related]
12. Formulation and optimization of topotecan nanoparticles: In vitro characterization, cytotoxicity, cellular uptake and pharmacokinetic outcomes. Padhi S; Kapoor R; Verma D; Panda AK; Iqbal Z J Photochem Photobiol B; 2018 Jun; 183():222-232. PubMed ID: 29729631 [TBL] [Abstract][Full Text] [Related]
13. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372 [TBL] [Abstract][Full Text] [Related]
14. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer. Ray S; Ghosh Ray S; Mandal S Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352 [TBL] [Abstract][Full Text] [Related]
15. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Chakravarthi SS; Robinson DH Int J Pharm; 2011 May; 409(1-2):111-20. PubMed ID: 21356285 [TBL] [Abstract][Full Text] [Related]
16. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Parveen S; Sahoo SK Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969 [TBL] [Abstract][Full Text] [Related]
17. Controlled-release of tetracycline and lovastatin by poly(D,L-lactide-co-glycolide acid)-chitosan nanoparticles enhances periodontal regeneration in dogs. Lee BS; Lee CC; Wang YP; Chen HJ; Lai CH; Hsieh WL; Chen YW Int J Nanomedicine; 2016; 11():285-97. PubMed ID: 26848264 [TBL] [Abstract][Full Text] [Related]
18. PLGA/SBA-15 mesoporous silica composite microparticles loaded with paclitaxel for local chemotherapy. Nanaki S; Siafaka PI; Zachariadou D; Nerantzaki M; Giliopoulos DJ; Triantafyllidis KS; Kostoglou M; Nikolakaki E; Bikiaris DN Eur J Pharm Sci; 2017 Mar; 99():32-44. PubMed ID: 27939620 [TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique. Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445 [TBL] [Abstract][Full Text] [Related]
20. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. Nafee N; Taetz S; Schneider M; Schaefer UF; Lehr CM Nanomedicine; 2007 Sep; 3(3):173-83. PubMed ID: 17692575 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]